These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 21415398)

  • 21. Long-term effect of additional rehabilitation following botulinum toxin-A on upper limb activity in chronic stroke: the InTENSE randomised trial.
    Lannin NA; Ada L; English C; Ratcliffe J; Faux S; Palit M; Gonzalez S; Olver J; Schneider E; Crotty M; Cameron ID
    BMC Neurol; 2022 Apr; 22(1):154. PubMed ID: 35468766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients.
    Hesse S; Krajnik J; Luecke D; Jahnke MT; Gregoric M; Mauritz KH
    Stroke; 1996 Mar; 27(3):455-60. PubMed ID: 8610313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of Botulinum Toxin Treatment for Upper Limb Spasticity Poststroke Over Different ICF Domains: A Systematic Review and Meta-Analysis.
    Andringa A; van de Port I; van Wegen E; Ket J; Meskers C; Kwakkel G
    Arch Phys Med Rehabil; 2019 Sep; 100(9):1703-1725. PubMed ID: 30796921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional and clinical changes in upper limb spastic patients treated with botulinum toxin (BTX).
    Panizza M; Castagna M; di Summa A; Saibene L; Grioni G; Nilsson J
    Funct Neurol; 2000; 15(3):147-55. PubMed ID: 11062843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of focal upper limb spasticity with botulinum toxin after stroke. Interest of an individual approach].
    Luauté J; Landrault E; Jacquin-Courtois S; Mertens P; Rode G; Boisson D
    Ann Readapt Med Phys; 2004 Oct; 47(8):555-62. PubMed ID: 15465160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes.
    McCrory P; Turner-Stokes L; Baguley IJ; De Graaff S; Katrak P; Sandanam J; Davies L; Munns M; Hughes A
    J Rehabil Med; 2009 Jun; 41(7):536-44. PubMed ID: 19543664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin.
    Marque P; Denis A; Gasq D; Chaleat-Valayer E; Yelnik A; Colin C; ; Pérennou D
    Ann Phys Rehabil Med; 2019 Jul; 62(4):207-213. PubMed ID: 31229700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity.
    Demetrios M; Khan F; Turner-Stokes L; Brand C; McSweeney S
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009689. PubMed ID: 23740539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
    Pandyan AD; Vuadens P; van Wijck FM; Stark S; Johnson GR; Barnes MP
    Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Spasticity and botulinum toxin in 2003. An update].
    Fève A
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):265-70. PubMed ID: 12746701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin type B in the spastic arm: a randomized, double-blind, placebo-controlled, preliminary study.
    Gracies JM; Bayle N; Goldberg S; Simpson DM
    Arch Phys Med Rehabil; 2014 Jul; 95(7):1303-11. PubMed ID: 24709034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and Safety of Botulinum Toxin Type A for Limb Spasticity after Stroke: A Meta-Analysis of Randomized Controlled Trials.
    Sun LC; Chen R; Fu C; Chen Y; Wu Q; Chen R; Lin X; Luo S
    Biomed Res Int; 2019; 2019():8329306. PubMed ID: 31080830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial.
    Bhakta BB; Cozens JA; Chamberlain MA; Bamford JM
    J Neurol Neurosurg Psychiatry; 2000 Aug; 69(2):217-21. PubMed ID: 10896696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can botulinum toxin decrease carer burden in long term care residents with upper limb spasticity? A randomized controlled study.
    Lam K; Lau KK; So KK; Tam CK; Wu YM; Cheung G; Liang KS; Yeung KM; Lam KY; Yui S; Leung C
    J Am Med Dir Assoc; 2012 Jun; 13(5):477-84. PubMed ID: 22521630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contemporary pharmacologic treatments for spasticity of the upper limb after stroke: a systematic review.
    Olvey EL; Armstrong EP; Grizzle AJ
    Clin Ther; 2010 Dec; 32(14):2282-303. PubMed ID: 21353101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
    Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
    Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double-blind, placebo-controlled trial.
    Hesse S; Reiter F; Konrad M; Jahnke MT
    Clin Rehabil; 1998 Oct; 12(5):381-8. PubMed ID: 9796928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin type B in upper-limb poststroke spasticity: a double-blind, placebo-controlled trial.
    Brashear A; McAfee AL; Kuhn ER; Fyffe J
    Arch Phys Med Rehabil; 2004 May; 85(5):705-9. PubMed ID: 15129392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of adding upper limb rehabilitation to botulinum toxin-A on upper limb activity after stroke: Protocol for the InTENSE trial.
    Lannin NA; Ada L; English C; Ratcliffe J; Crotty M
    Int J Stroke; 2018 Aug; 13(6):648-653. PubMed ID: 29553309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Automatic EMG-guided botulinum toxin treatment of spasticity.
    Finsterer J; Fuchs I; Mamoli B
    Clin Neuropharmacol; 1997 Jun; 20(3):195-203. PubMed ID: 9197941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.